FinnGen-aineistoa hyödyntänyt LL Joel Räsäsen normaalipaineisen hydrokefalian eli NPH-taudin geneettistä taustaa käsittelevä väitöskirja tarkastetaan tänään Itä-Suomen yliopiston terveystieteiden tiedekunnassa Kuopion kampuksella. Tilaisuutta voi seurata myös verkossa: www.uef.fi/fi/artikkeli...

Comment🚨 Large biobank projects like #FinnGen help in uncovering genetic factors that influence cancer risk and outcomes, enhancing risk prediction & biomarker and drug target discovery. @finngen.bsky.social @dalygene.bsky.social @aoxing2.bsky.social#FinnGen 📖 👇

If you are in or around Turku tomorrow, don’t miss Prof. Mark Daly’s @biocityturku.bsky.social guest seminar highlighting the latest FinnGen discoveries! 📆21st Oct at 12:00-13:00, Presidentti auditorium, BioCity Title: FinnGen and the road ahead in human genetics 🔗 biocityturku.fi/events/bioci...

Day 4 at #ASHG2025 and the FinnGen team is still going strong! 💪🧬 Visit today’s FinnGen posters (see the thread) and swing by booth #147 for some Finnish candies and great conversation!

Excited (😁) to share a commentary on @finngen.bsky.social & cancer research, co-written with Mervi Aavikko & @dalygene.bsky.social!! (View-only full text -> rdcu.be/eLlJs)

So much great FinnGen science on display again today at #ASHG2025! Make sure to visit the posters listed here, and stop by at our booth (# 147) for some Finnish salmiakki!

Here’s a look at today’s FinnGen-related posters at #ASHG25, showcasing some of our research community's latest discoveries.

#ASHG2025 in Boston is off to a great start! The FinnGen team is ready and waiting for you at Booth #147! Come say hi, explore insights from one of the world’s largest genomics initiatives and grab a FinnGen canvas bag (and other goodies)!

Just in time for #ASHG2025, a new FinnGen public data release is live! This release features the first clinical laboratory value association results. Analyses cover 383 lab measurements (OMOPIDs) with data from ≥1,000 participants each. Access the results here: www.finngen.fi/en/access_re...

We’re getting ready for an exciting week at #ASHG2025 in Boston! Come meet the FinnGen team at booth 147 - we’ll be sharing updates and showcasing new public resources and tools. Plus, don’t miss the various presentations featuring FinnGen results across the program! www.finngen.fi/en/meet-finn...

💥 New preprint & our first RCT! 💥 Does an extremely high or low BMI polygenic score influence weight loss after a diet intervention? GENEROOS is a 6-month randomized diet vs. control trial testing if genetic predisposition to higher BMI affects weight loss in overweight adults

FinnGen is in the spotlight! In EP 204 of #TheGeneticsPodcast, Prof. @sripatti.bsky.social, director of @fimm-uh.bsky.social, discusses how FinnGen’s data are helping translate genetics into real-world clinical tools, such as polygenic risk scores & treatment prediction. 🎙️ pod.fo/e/328c49

This week, ~230 national and international FinnGen partner researchers came together in Helsinki for our annual F2F-meeting at Kalastajatorppa. The excellent scientific presentations and exchange of ideas will help shape the next phase of FinnGen and advance our scientific goals. Thank you!

Congratulations to the winners of the FinnGen Publication Prize 2025! 🎉 🏆 Jakob German (FIMM/UH) 🏆 Ville Salo (University of Oulu) This annual prize is announced during our F2F meeting, celebrating outstanding science from the past year. A big thank you to Scellex for sponsoring this year’s prize!

It's the FinnGen Helsinki F2F time of the year! Our Scientific Director Aarno Palotie just kicked off this year's meeting by warmly welcoming our international and local guests. The next two days will be all about exciting science, great discussions, and catching up with colleagues.

Our trisomy work is now online! 🚀 Got curious after reading our short PheWAS paper? 👀 Catch me 🌠 & my talk 🎤 this October at #ASHG25 in Boston! Yes, I am still endlessly curious about sex chromosome aneuploidies - whether it's somatic (X/Y loss) or germline (trisomies)!! 💘

📣Online now! 📄 #PheWAS of male and female sex chromosome trisomies in 1.5 million participants of MVP, FinnGen, and UK Biobank @finngen.bsky.social @ukbiobank.bsky.social

We are looking for a Data Scientist to support our clinically oriented research teams in generating insights from decades of rich, longitudinal health data. If you are inspired by the opportunity to contribute to cutting-edge research at a global scale, apply here: jobs.helsinki.fi/job/Helsinki...

📢 Another month, another set of impactful studies! Here are the papers published in July 2025 that utilized FinnGen data and credited us as a co-author. Exciting to see our resource advancing science across medical fields. Thread👇 #FinnGen #genetics

A new FinnGen-based study by researchers from Tampere University & @ki.se has identified genetic variants linked to brain function, immune defence and metabolism that contribute to the development of frailty in older people. #genomics #research news.ki.se/genes-reveal...

📢 Our newest batch of scientific publications! 📢 Here are the papers published during June 2025 that used FinnGen data and credited us as a co-author. Thread👇 #FinnGen #genetics

📢 A fresh batch of scientific discoveries! Here are the papers published in May 2025 that used FinnGen data and credited us as a co-author. Thread👇 #FinnGen #genetics

Suomalaisessa väestössä esiintyvä harvinainen TYROBP-geenimuutos lisää riskiä sairastua Alzheimerin tautiin, osoitti Itä-Suomen yliopiston johtama, FinnGeniä hyödyntänyt tutkimus. Geenimuutos vaikuttaa aivojen tulehdusta säätelevien mikrogliasolujen toimintaan. www.uef.fi/fi/artikkeli...

📢 Here comes a list of papers published in April 2025, where FinnGen has been utilized and listed as a co-author. Great to see our data driving such an impactful science! Thread👇 #FinnGen #genetics

Jyväskylän yliopiston tutkijat ovat osoittaneet FinnGenin avulla, että paikallaanololle altistava geeniperimä on yhteydessä suurempaan riskiin sairastua sydän- ja verisuonitauteihin. Suuri geneettinen alttius paikallaanoloon voi lisätä sairastumisriskiä jopa 20 %. 🔗 www.finngen.fi/fi/paikallaa...

Researchers @uniofjyvaskyla.bsky.social utilised FinnGen to show that genetic predisposition to sedentary behaviour is associated with a higher cardiovascular disease risk. A high genetic predisposition to sedentary behaviour can increase the CVD risk by up to 20%. 🔗 www.finngen.fi/en/genetic-p...

Last week, we organized our FinnGen Face-to-Face plenary meeting in Boston, bringing together 150 participants. Warm thanks to Sanofi for hosting us! The sessions highlighted new discoveries, explored fresh results based on omics and lab value data, and discussed the future of FinnGen.

Join us April 8-9 for @geneticssociety.bsky.social Spring Symposium on Cancer Genetics!! 🧬 I will present our work on #mCAs & #solid_tumors in @finngen.bsky.social. Register link: learning.ashg.org/products/202... Excited to connect with you virtually months before the Boston annual meeting!! 🫶

New PhD thesis based on FinnGen data! MSc Jonna Clancy studied the genetic structure of a blood donor-based biobank in Finland, using genome and proteomics data from FinnGen. Results show the unique genetic structure of active donors caused by the healthy donor effect. www.finngen.fi/en/doctoral-...

Nice paper showing ~1/540 people have a sex chromosome trisomy from 3 large biobanks (UKB, FinnGen, MVP) comprising 1.5 million individuals along with their phenotypic impact. www.medrxiv.org/content/10.1...

Uusia FinnGen-aineistoon perustuvia tuloksia! @unioulu.bsky.social johtamassa kansainvälisessä tutkimuksessa löydettiin 6 geenialuetta, jotka liittyvät silmän värikalvon tulehduksen eli iriitin kehittymiseen. Löydökset auttavat ymmärtämään iriitin syntymekanismeja ja yhteyttä autoimmuunisairauksiin.

New FinnGen based findings from @unioulu.bsky.social researchers! This international study identified six genetic regions associated with the inflammation of the eye's iris, also known as anterior uveitis. Original publication: doi.org/10.1136/bjo-...

Tänään pääsimme kertomaan FinnGenin edistymisestä ja lähitulevaisuuden suunnitelmista yrityspartneriemme paikallisille edustajille. Lämmin kiitos kaikille mukaan päässeille hyvästä keskustelusta!

FinnGen team wishes you a peaceful holiday season! As we reflect on the progress made this year, we are grateful to every participant and collaborator who has contributed to our genetic research journey. We look forward to making more exciting discoveries together in 2025!

Suulakihalkioiden esiintyvyys Suomessa on yli kaksinkertainen Euroopan keskiarvoon verrattuna. Uudet FinnGen-aineistoon perustuvat tulokset auttavat selittämään tätä ilmiötä. Suomesssa poikkeuksellisen yleinen IRF6-geenin säätelyalueelta tunnistettu variantti lisää selvästi suulakihalkion riskiä.

Million Veteran Program & FinnGen teams are pleased to release v1 meta-analysis of MVP, FinnGen and UKBB GWAS data. This first version includes ~300 binary disease definitions across >1.5 M individuals. Browse scans at: mvp-ukbb.finngen.fi

We are delighted to welcome Bayer as our newest pharmaceutical industry partner! Their expertise in the Nordic healthcare ecosystem and commitment to advancing pharmaceutical R&D in Finland will further strengthen FinnGen’s scientific mission. Read more 🔽

Last autumn FinnGen hit its target of sampling close to 10% of the Finnish population with more than 500,000 participants. The results based on the full cohort are publicly available for the whole research community (using our PheWeb browser or downloadable): www.finngen.fi/en/results-b...

Introducing FinnGen, a public-private genomics research consortium!🧬 By analysing genetic data from >500,000 Finnish biobank participants and linking it to health records, FinnGen leverages Finland’s unique advantages to drive genetic discoveries. Follow along for updates on our progress & findings!